Medtronic plc (MDT) Stock
NYSEMDT has an Alpha Score of 54 out of 100 (weak), computed on Oct 28, 2026 from 3 of 4 sub-scores. 48 members of Congress disclosed 117 trades in MDT since 2015: 58 purchases and 56 sales, most recently Kevin Hern (sale, Aug 24, 2026). Company insiders reported 0 open-market buys and 3 sales on SEC Form 4 in the 90 days to Oct 30, 2026. Its trailing P/E ratio is 23.2 and its net margin 13.9% (key statistics as of Oct 22, 2026).
What is MDT's Alpha Score?
How it works →Alpha Score of 54 reflects moderate overall profile with moderate momentum, moderate value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 28, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded Medtronic plc (MDT)?
Most recent: Kevin Hern (sale, Aug 24, 2026); records start Jan 21, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Kevin Hern R-OK · House | 2026-08-24 | sale | $15k – $50k |
| Rich McCormick R-GA · House | 2026-07-30 | sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2026-05-15 | partial sale | $1k – $15k |
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| Kevin Hern R-OK · House | 2026-03-20 | sale | $15k – $50k |
| Julie Johnson D-TX · House | 2025-12-18 | sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-11-13 | partial sale | $1k – $15k |
| Rich McCormick R-GA · House | 2025-11-05 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded MDT, with filing lags →Are Medtronic plc insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 15, 26 | Martha Geoffrey | Chairman and CEO | SELL | 50.0K | $4.8M |
| Oct 15, 26 | Marinaro Michael | EVP, Pres MedSurg and Americas | SELL | 10.4K | $1.0M |
| Sep 16, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 1.5K | $139K |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 668 | $65K |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 385 | $38K |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 1.6K | $161K |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 30.6K | $3.0M |
| Feb 19, 26 | Kiil Harry Skip | EVP & President Cardiovascular | SELL | 19.3K | $1.9M |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 325 | $33K |
| Nov 19, 25 | Smith Gregory L | EVP Global Ops & Supply Chain | SELL | 500 | $51K |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are MDT's key statistics?
Key statistics as of Oct 22, 2026
How does MDT's valuation compare with the Healthcare sector?
| Metric | MDT | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 23.2 | 27.1 | 97 |
| Net margin | 13.94% | 5.48% | 139 |
| Return on equity | 10.61% | 6.84% | 158 |
| Dividend yield (payers) | 3.50% | 1.62% | 50 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
MDT price chart
Powered by TradingViewWhat does Medtronic plc do?
Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Cardiovascular, which includes cardiac ablation solutions, rhythm management, surgery, coronary and renal denervation, mechanical circulatory support, peripheral vascular health, structural heart and aortic products; Diabetes, offering therapies and services for insulin-dependent individuals with Type 1 and Type 2 diabetes; Medical Surgical, encompassing surgical endoscopy and acute care and monitoring; and Restorative Therapies, covering cranial and spinal technologies, neuromodulation, neurovascular, pelvic health, gastric therapies, and ear, nose, and throat solutions. Medtronic plc produces innovative products such as implantable pacemakers, cardioverter-defibrillators, spinal cord stimulators, insulin pumps, and remote monitoring systems, serving patients in hospitals, homes, and surgical settings worldwide. Founded in 1949 and legally headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota, it focuses on advancing healthcare through minimally invasive therapies, disease management, and patient monitoring technologies in more than 150 countries.